[Recommendations] AMR Alliance Japan Recommendations Toward Stronger AMR Countermeasures in the 2021 Basic Policies for Economic and Fiscal Management and Reform (June 10, 2021)
date : 6/10/2021
Tags: AMR
On June 10, 2021, AMR Alliance Japan (Secretariat: Health and Global Policy Institute) released “AMR Alliance Japan Recommendations Toward Stronger AMR Countermeasures in the 2021 Basic Policies for Economic and Fiscal Management and Reform.” The content of the recommendations was as follows.
・・・
Each year, at least 700,000 people worldwide, including 8,000 people in Japan, are estimated to die from antimicrobial resistance (AMR) related causes.
For many years since 2016, the Japanese Government’s Basic Policies for Economic and Fiscal Management and Reform has included the clause, ” For countermeasures against infectious disease and antimicrobial resistance, the government will promote domestic measures, including enhancement of system of research, inspection and treatment, and an international framework,” recognizing the importance of this issue.
AMR Alliance Japan recommends that the following wording be included in the 2021 Basic Policies to promote health crisis preparedness related to AMR infectious diseases. The Alliance believe it is important for Japan to fulfill its responsibilities to the international community since victory over infectious diseases cannot be achieved by any one country alone.
“For countermeasures against infectious disease and antimicrobial resistance, the government will strengthen systems for surveillance, screening, human resource development, and the stable supply of antimicrobials. The government will also soon establish systems for the sustainable research and development of antimicrobials, and play a leading role in international cooperation.”
This proposal is in line with the text of communique’s out of the G7. The G7 Health Ministers’ Meeting held on June 3-4, 2021, confirmed that G7 countries would “seek to overcome the economic barriers to an endurable supply of antimicrobial products and to ensure sustainable innovation in antimicrobial R&D while encouraging appropriate provisions for stewardship, diversity and security of supply chains, environmental protection in manufacturing and disposal, and global access.” The G7 Finance Ministers’ Meeting held on June 4-5, 2021, also stated We will work together with our health colleagues in the second half of this year, including with industry, to explore proposals for strengthening market incentives for antibiotic drug development to help tackle antimicrobial resistance – the ‘silent pandemic.’”
Top Research & Recommendations Posts
- [Survey Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Preliminary Version) (September 11, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Policy Recommendations] Three Necessary Perspectives for Formulating the Basic Plan for the Promotion of Policies on Dementia: Creating a Society That is Inclusive for All People at All Times (April 1, 2024)
- [Policy Recommendations] Dementia Policy for an Inclusive Society 2024: HGPI Recommendations on The Basic Plan on Dementia to Promote an Inclusive Society (Draft) and Basic Measures (Draft) (August 13, 2024)
Featured Posts
-
2024-07-03
[Japanese Version Release] “Call for Actionable Steps in Response to the Rising Threat of Antimicrobial Resistance (AMR)” (July 3, 2024)
-
2024-09-26
[Event Report] UN General Assembly High-Level Meeting on AMR Side Event “Global Action on AMR: Advancing Healthy Longevity and Sustainability under UHC” (September 25, 2024, New York City, USA)
-
2024-09-26
[Registration Open] HGPI Salon Special Edition “The 2024 U.S. Presidential Election’s Impact on Japan’s Healthcare Policies: Future Implications for U.S.-China Relations and U.S.-Japan Cooperation” (October 28, 2024)
-
2024-09-27
[HGPI Policy Column] (No. 48) From the Meaningful Involvement Promotion Project: The Resolution on Social Participation at the 77th World Health Assembly
-
2024-10-01
[Event Report] Online Information Session for Japan’s Patient Expert Platform (J-PEP), a Members Only Website (September 6, 2024)